From a metabolic perspective, elevated TBA levels reflect hepatic dysfunction and may remodel the tumor microenvironment through bile acid receptor-mediated pathways (e.g., FXR, TGR5) (11, 28). The gene discussed is GPBAR1; the disease is neoplasm.